The COVID-19 Pandemic – Products

Zapnometinib is now ready for clinical development in severe influenza, an area without approved therapies and with a rapidly evolving pandemic threat from bird flu virus H5N1.

Fluidic Sciences Ltd., announces its official launch as a company, and the commercial relaunch of the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution—leveraging Microfluidic Diffusional Sizing (MDS) technology.

TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility.

China shifts its focus to thermal imaging technologies, securing 50% of worldwide shipments in 2023.

With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care. To achieve this, Bosch has now agreed on a strategic partnership with Randox Laboratories Ltd.

This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.

Fluid and cold chain management expert Single Use Support has opened a subsidiary in Lexington, Massachusetts. Equipped with a product showroom, the office will also serve as a base for increased US staff.

The Noramco group addresses critical supply chain challenges, offering comprehensive active pharmaceutical ingredients (API) and drug product solutions.

This application note explores a qualified method designed to produce high-quality sequencing libraries, using a hybrid-capture resequencing approach to increase throughput and reproducibility while minimizing the potential for human error.

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.